The YY1/HDAC2 complex could inhibit the expression of YTHDC1 and promot sunitinib sensitivity via HDAC2/YY1/YTHDC1/ANXA1 axis in RCC. Here, HDAC2 is linked to renal cell adenocarcinoma.